AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
More than 13 tons of donations were collected at the joint Easter campaign of NOE and CBA
More than 13 tons of donations were collected during the…
Read more >Digital detox during Easter: addictive phone use is a much more serious and widespread problem than we think
The Easter fast is traditionally a time of introspection, renunciation,…
Read more >Cruel April frost damage: up to 100% crop loss possible
The spring frosts in early April once again caused a…
Read more >